About Joseph Saladino
Joseph Saladino is CEO and director at Marrow Access Technologies.
Joseph Saladino first appears on SEC filings in 2018.
Experience
This experience comes from Joseph Saladino's profile and from SEC filings. For roles taken from filings, the years are when the filings name Joseph Saladino in the role, so the role may have started earlier or lasted longer.
VL
Vail Scientific, LLC Current
Chief Executive Officer
2026 – Present
OC
Orthopedic Innovation Consortium Current
Co-Founder and Chair
2024 – Present
EL
Endgame MedTech LLC Current
Managing Director and Principal
2019 – Present
Marrow Access Technologies, Inc. Current
CEO and director
Co-Founder and Chair of the Board (2017 – Present)
2017 – Present · Eden Prairie, MN
Marrow access devices for surgeons treating patients with cartilage defects.
ME
Medtronic
Head of Global Commercialization, Atrial Fibrillation Solutions
1999 – 2018
ZY
Zyga
Vice President of Marketing
2014 – 2015
AR
Arthrex
Head of Knee and Hip Product Development
2004 – 2005
ZI
Zimmer
Product Development Engineer
2000 – 2003
OC
Ortho Development Corporation
Product Development Engineer
2000
SI
Southwest Research Institute
Intern - Bioengineering Division
1998
Key Colleagues at Startups
The people Joseph Saladino works with at each company, as listed on that company's latest Form D.
Marrow Access Technologies, Inc. · Form D, Apr 9, 2026
JK
Jason Koh
Executive officer and director
PV
Paul Verrastro
Director
DF
Dan Fisher
Director
KF
Kevin Foley
Director
JC
Jim Cloar
Director